Methods and Protocols (Dec 2022)

Development and Characterization of a Luminescence-Based High-Throughput Serum Bactericidal Assay (L-SBA) to Assess Bactericidal Activity of Human Sera against Nontyphoidal <i>Salmonella</i>

  • Maria Grazia Aruta,
  • Daniele De Simone,
  • Helen Dale,
  • Esmelda Chirwa,
  • Innocent Kadwala,
  • Maurice Mbewe,
  • Happy Banda,
  • Melita Gordon,
  • Mariagrazia Pizza,
  • Francesco Berlanda Scorza,
  • Tonney Nyirenda,
  • Rocío Canals,
  • Omar Rossi,
  • on behalf of the Vacc-iNTS Consortium Collaborators

DOI
https://doi.org/10.3390/mps5060100
Journal volume & issue
Vol. 5, no. 6
p. 100

Abstract

Read online

Salmonella Typhimurium and Salmonella Enteritidis are leading causative agents of invasive nontyphoidal Salmonella (iNTS) disease, which represents one of the major causes of death and morbidity in sub-Saharan Africa, still partially underestimated. Large sero-epidemiological studies are necessary to unravel the burden of disease and guide the introduction of vaccines that are not yet available. Even if no correlate of protection has been determined so far for iNTS, the evaluation of complement-mediated functionality of antibodies generated towards natural infection or elicited upon vaccination may represent a big step towards this achievement. Here we present the setup and the intra-laboratory characterization in terms of repeatability, intermediate precision, linearity, and specificity of a high-throughput luminescence-based serum bactericidal assay (L-SBA). This method could be useful to perform sero-epidemiological studies across iNTS endemic countries and for evaluation of antibodies raised against iNTS vaccine candidates in upcoming clinical trials.

Keywords